Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by aberrant fibroblast activation and progressive fibrotic remodelling of the lungs. Though the exact pathophysiological mechanisms of IPF remain unknown, TGF-β1 is thought to act as a main driver of...
Main Authors: | Eva Schruf, Victoria Schroeder, Christian A. Kuttruff, Sabine Weigle, Martin Krell, Maryke Benz, Tom Bretschneider, Alexander Holweg, Michael Schuler, Manfred Frick, Paul Nicklin, James P. Garnett, Mirko C. Sobotta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1058-2 |
Similar Items
-
Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis
by: Chenxi Zeng, et al.
Published: (2024-10-01) -
The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII
by: Liangmei Chen, et al.
Published: (2023-05-01) -
Advances in macrophage-myofibroblast transformation in fibrotic diseases
by: Jia-Qi Ban, et al.
Published: (2024-10-01) -
Regulation of myofibroblast dedifferentiation in pulmonary fibrosis
by: Xuetao Ju, et al.
Published: (2024-07-01) -
Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism
by: Xiujun Li, et al.
Published: (2024-09-01)